WallStSmart
CYTK

Cytokinetics Inc

NASDAQ: CYTK · HEALTHCARE · BIOTECHNOLOGY

$63.97
+7.37% today

Updated 2026-04-30

Market cap
$7.54B
P/E ratio
P/S ratio
85.64x
EPS (TTM)
$-6.54
Dividend yield
52W range
$29 – $71
Volume
1.9M

Cytokinetics Inc (CYTK) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$3.13M$13.62M$12.42M$81.54M$2.58M$4.00M$7.56M$30.65M$46.94M$28.66M$106.41M$13.37M$31.50M$26.87M$55.83M$70.43M$94.59M$7.53M$18.47M$88.04M
Revenue growth (YoY)+335.6%-8.8%+556.5%-96.8%+55.2%+89.0%+305.5%+53.2%-38.9%+271.3%-87.4%+135.6%-14.7%+107.8%+26.2%+34.3%-92.0%+145.3%+376.6%
Cost of revenue$61.54M$67.28M$66.57M$53.45M$50.31M$49.48M$35.64M$49.45M$44.43M$46.40M$59.90M$90.30M$89.14M$86.13M$96.95M$159.94M$240.81M$330.12M$339.41M$10.13M
Gross profit$3.13M$13.62M$12.42M$81.54M$2.58M$4.00M$-28.08M$-18.80M$2.51M$-17.74M$46.51M$-76.93M$-57.63M$-59.26M$-41.12M$-89.51M$-146.22M$-322.59M$-320.93M$77.91M
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%-371.5%-61.3%5.4%-61.9%43.7%-575.5%-183.0%-220.5%-73.7%-127.1%-154.6%-4284.1%-1737.2%88.5%
R&D$49.23M$53.39M$53.95M$39.84M$38.01M$37.18M$35.64M$49.45M$44.43M$46.40M$59.90M$90.30M$89.14M$86.13M$96.95M$159.94M$240.81M$330.12M$339.41M$405.90M
SG&A$15.24M$16.72M$15.08M$15.63M$14.20M$13.59M$11.72M$15.09M$17.27M$19.67M$27.82M$36.47M$31.28M$39.61M$52.82M$96.80M$177.98M$173.61M$215.31M$284.27M
Operating income$-61.34M$-56.49M$-59.08M$26.09M$-49.63M$-47.96M$-39.10M$-33.89M$-14.75M$-37.41M$18.69M$-113.40M$-88.92M$-98.87M$-93.94M$-186.31M$-324.20M$-496.20M$-536.25M$-612.26M
Operating margin-1961.6%-414.7%-475.7%32.0%-1926.1%-1199.1%-517.3%-110.6%-31.4%-130.5%17.6%-848.3%-282.3%-368.0%-168.3%-264.5%-342.8%-6589.7%-2902.7%-695.4%
EBITDA$-53.66M$-45.37M$-53.43M$27.12M$-47.73M$-46.52M$-39.78M$-33.46M$-14.26M$-36.82M$19.43M$-108.89M$-83.49M$-93.04M$-86.78M$-176.34M$-329.40M$-456.68M$-493.48M$-775.27M
EBITDA margin-1715.9%-333.0%-430.2%33.3%-1852.3%-1163.1%-526.2%-109.2%-30.4%-128.5%18.3%-814.6%-265.0%-346.3%-155.4%-250.4%-348.2%-6064.9%-2671.2%-880.6%
EBIT$-56.58M$-48.20M$-55.88M$25.10M$-49.63M$-47.82M$-40.37M$-33.89M$-14.75M$-37.41M$18.69M$-110.79M$-84.72M$-94.33M$-88.61M$-185.98M$-337.80M$-468.58M$-503.01M$-784.96M
Interest expense$523000.00$699000.00$491000.00$409000.00$163000.00$104000.00$2000.00$177000.00$108000.00$94000.00$2.23M$17.00M$21.56M$27.36M$38.68M$29.33M$51.16M$57.67M$86.51M$103.87M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-57.12M$-48.89M$-56.37M$24.54M$-49.29M$-47.86M$-41.68M$-33.72M$-14.65M$-37.50M$16.45M$-127.79M$-106.29M$-121.69M$-127.29M$-215.31M$-388.95M$-526.24M$-589.53M$-784.96M
Net income growth (YoY)+14.4%-15.3%+143.5%-300.8%+2.9%+12.9%+19.1%+56.6%-156.0%+143.9%-876.7%+16.8%-14.5%-4.6%-69.2%-80.6%-35.3%-12.0%-33.2%
Profit margin-1826.5%-358.9%-453.9%30.1%-1912.6%-1196.5%-551.4%-110.0%-31.2%-130.9%15.5%-955.9%-337.4%-452.9%-228.0%-305.7%-411.2%-6988.6%-3191.1%-891.6%